Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery

Autor: Paganelli F, Mc, Alessi, Pierre Morange, Jm, Maixent, Lévy S, Ij, Vague

Publikováno v: Europe PubMed Central

Type 1 plasminogen activator inhibitor (PAI-1) is considered to be risk factor for acute myocardial infarction (AMI). A rebound of circulating PAI-1 has been reported after rt-PA administration. We investigated the relationships between PAI-1 levels

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1b388ed458766b607970348d0dcd75a8
https://pubmed.ncbi.nlm.nih.gov/10456462

Omegacoeur, a Mediterranean nutritional complement, stimulates Na,K-ATPase activity in human endothelial cells

Autor: Mj, Duran, Sabatier F, Pieroni G, Ghislaine Gerber, Sampol J, Jm, Maixent

Publikováno v: Europe PubMed Central

Fatty acids are known as modulators of the vasoactive properties of the vessel wall and can influence the physical and functional properties of cell membrane. The membrane-bound enzyme Na,K-ATPase plays a central role in endothelial function such as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ecbce1cee3aabac9667d70289105de6c
http://europepmc.org/abstract/med/11355006

Biological Activities and Polyphenol Content of Qi Cha Tea ^® , a Functional Beverage of White Tea Containing Botanicals and Dry Botanical Extracts with European Health Claims.

Autor: Maixent JM; Pierre Deniker Clinical Research Unit, Henri Laborit University Hospital, University of Poitiers, F-86000 Poitiers, France.; Laboratory Impact of Physical Activity, Health (I.A.P.S.) Toulon University, F-83000 Toulon, France.; School of Sciences, Poitiers University, F-86000 Poitiers, France., Belaiba M; Laboratoire de Génie Chimique, University Paul Sabatier, CNRS, INPT, UPS, F-31100 Toulouse, France., Pons O; Laboratory Impact of Physical Activity, Health (I.A.P.S.) Toulon University, F-83000 Toulon, France., Roulleau E; Pierre Deniker Clinical Research Unit, Henri Laborit University Hospital, University of Poitiers, F-86000 Poitiers, France.; School of Sciences, Poitiers University, F-86000 Poitiers, France.; Thés de la Pagode, 4, Avenue Bertie Albrecht, 75008 Paris, France., Bouajila J; Laboratoire de Génie Chimique, University Paul Sabatier, CNRS, INPT, UPS, F-31100 Toulouse, France., Zeil JM; Thés de la Pagode, 4, Avenue Bertie Albrecht, 75008 Paris, France.

Publikováno v: Plants (Basel, Switzerland) [Plants (Basel)] 2023 Sep 11; Vol. 12 (18). Date of Electronic Publication: 2023 Sep 11.

Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases.

Autor: Gaudry M; Department of Vascular Surgery, Timone Hospital, F-13008 Marseille, France., Vairo D; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France., Marlinge M; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France.; Laboratory of Biochemistry, Timone Hospital, F-13008 Marseille, France., Gaubert M; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France., Guiol C; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France., Mottola G; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France.; Laboratory of Biochemistry, Timone Hospital, F-13008 Marseille, France., Gariboldi V; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France.; Department of Cardiac Surgery, Timone Hospital, F-13008 Marseille, France., Deharo P; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France.; Department of Cardiology, Timone Hospital, F-13008 Marseille, France., Sadrin S; Laboratoire Denel-Codifra, F-78150 Le Chesnay, France., Maixent JM; Unité de Recherche Clinique Pierre Deniker (URC C.S. 10587) Centre Hospitalier Henri Laborit, 86000 Poitiers, France.; I.A.P.S. Equipe Emergeante, Université de Toulon, 83957 Toulon-La Garde, UFR S.F.A., F-86073 Poitiers, France., Fenouillet E; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France., Ruf J; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France., Guieu R; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France.; Laboratory of Biochemistry, Timone Hospital, F-13008 Marseille, France., Paganelli F; C2VN, INSERM, INRA, Aix-Marseille University, F-13015 Marseille, France.; Department of Cardiology, Nord Hospital, ARCHANTEC, F-13015 Marseille, France.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2020 Jul 27; Vol. 21 (15). Date of Electronic Publication: 2020 Jul 27.

Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives.

Autor: Maixent JM; Pierre Deniker Clinical Research Unit, Henri Laborit University Hospital, Poitiers, France., Pons O; IAPS Laboratory, University of Toulon, Toulon, France., Sennoune SR; Department of Cellular Physiology and Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, USA., Sadrin S; Laboratoire Denel-Codifra, Le Chesnay, France.

Publikováno v: Cellular and molecular biology (Noisy-le-Grand, France) [Cell Mol Biol (Noisy-le-grand)] 2020 Jun 05; Vol. 66 (3), pp. 211-214. Date of Electronic Publication: 2020 Jun 05.